Immunotherapy Clinical Trial Aims to Combat Brain Cancer

2020-03-31T00:58:27+00:00

Immunotherapy Clinical Trial Aims to Combat Brain Cancer A Phase 2/3 clinical trial called Toca 5 - investigating a retroviral gene therapy treatment in patients with recurrent brain cancer - is actively enrolling at Atlantic NeuroSurgical Specialists (ANS). Dr. Yaron Moshel, a neurosurgeon at Altair Health and co-director of the Gerald [...]

Immunotherapy Clinical Trial Aims to Combat Brain Cancer2020-03-31T00:58:27+00:00

ANS’s Dr. Paul Saphier Leads New Jersey Arm of Global Clinical Trial to Improve the Standard of Care for Brain Bleeds

2020-03-31T01:47:39+00:00

ANS’s Dr. Paul Saphier Leads New Jersey Arm of Global Clinical Trial to Improve the Standard of Care for Brain Bleeds Atlantic NeuroSurgical Specialists challenges status quo with adoption of new minimally invasive technology to treat patients with hemorrhagic strokes ANS’s Dr. Paul Saphier, pictured here with the Artemis Neuro Evacuation [...]

ANS’s Dr. Paul Saphier Leads New Jersey Arm of Global Clinical Trial to Improve the Standard of Care for Brain Bleeds2020-03-31T01:47:39+00:00

Altair Health Neurosurgeon Seeks Patients with Spondylolisthesis and Spinal Stenosis to Enroll in Clinical Trial and Potentially Receive Motion-Preserving Device

2020-04-23T21:06:53+00:00

Altair Health Neurosurgeon Seeks Patients with Spondylolisthesis and Spinal Stenosis to Enroll in Clinical Trial and Potentially Receive Motion-Preserving Device Board-certified neurosurgeon participates in FDA/IDE study examining use of TOPS™ System Dr. Scott Meyer, a board-certified neurosurgeon at Altair Health – one of the nation’s first physician-managed healthcare systems devoted to comprehensive [...]

Altair Health Neurosurgeon Seeks Patients with Spondylolisthesis and Spinal Stenosis to Enroll in Clinical Trial and Potentially Receive Motion-Preserving Device2020-04-23T21:06:53+00:00
Go to Top